Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09LHN
|
||||
Former ID |
DNC004741
|
||||
Drug Name |
Des-AA1,2,5-[IAmp9,Tyr11]-SRIF
|
||||
Indication | Discovery agent | Investigative | [527384] | ||
Structure |
Download2D MOL |
||||
Formula |
C74H96N14O16S2
|
||||
Canonical SMILES |
CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(<br />C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)C<br />C3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=<br />O)O)CO)C(C)O)CC7=CC=C(C=C7)O)C(C)O
|
||||
InChI |
1S/C74H96N14O16S2/c1-41(2)77-36-48-24-22-46(23-25-48)33-57-69(98)87-62(42(3)90)72(101)84-58(34-47-26-28-50(92)29-27-47)70(99)88-63(43(4)91)73(102)85-60(38-89)71(100)86-61(74(103)104)40-106-105-39-52(76)64(93)79-54(21-13-14-30-75)65(94)80-55(31-44-15-7-5-8-16-44)66(95)81-56(32-45-17-9-6-10-18-45)67(96)83-59(68(97)82-57)35-49-37-78-53-20-12-11-19-51(49)53/h5-12,15-20,22-29,37,41-43,52,54-63,77-78,89-92H,13-14,21,30-36,38-40,75-76H2,1-4H3,(H,79,93)(H,80,94)(H,81,95)(H,82,97)(H,83,96)(H,84,101)(H,85,102)(H,86,100)(H,87,98)(H,88,99)(H,103,104)/t42-,43-,52-,54-,55-,56+,57+,58+,59-,60+,61+,62-,63-/m1/s1
|
||||
InChIKey |
FJRAPOZDHJLSPN-KVMFXWMESA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Somatostatin receptor type 4 | Target Info | Inhibitor | [527384] | |
Somatostatin receptor 1 | Target Info | Inhibitor | [527384] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
PathWhiz Pathway | Gastric Acid Production | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.